P.S., I think you are reaching on Flemming questioning the trial design being N/I, but I will wait to I see the real transcript before I say any more here.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.